Literature DB >> 27809515

Structure-Cytotoxicity Relationships of Analogues of N14-Desacetoxytubulysin H.

Dorin Toader1,2, Fengjiang Wang1, Lakshmaiah Gingipalli1, Melissa Vasbinder1, Mark Roth1, Shenlan Mao3, Michael Block1, Jay Harper3, Sambaiah Thota1, Mei Su1, Jianquo Ma1, Vahe Bedian1, Adeela Kamal3.   

Abstract

Herein we report structure-cytotoxicity relationships for analogues of N14-desacetoxytubulyisn H 1. A novel synthetic approach toward 1 enabled the discovery of compounds with a range of activity. Calculated basicity of the N-terminus of tubulysins was shown to be a good predictor of cytotoxicity. The impact of structural modifications at the C-terminus of 1 upon cytotoxicity is also described. These findings will facilitate the development of new tubulysin analogues for the treatment of cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27809515     DOI: 10.1021/acs.jmedchem.6b01023

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Diastereocontrol in Radical Addition to β-Benzyloxy Hydrazones: Revised Approach to Tubuvaline and Synthesis of O-Benzyltubulysin V Benzyl Ester.

Authors:  Manshu Li; Koushik Banerjee; Gregory K Friestad
Journal:  J Org Chem       Date:  2021-10-12       Impact factor: 4.354

2.  Highly stereoselective gram scale synthesis of all the four diastereoisomers of Boc-protected 4-methylproline carboxylates.

Authors:  Kehuan Sun; Cheng Tao; Bohua Long; Xiaobin Zeng; Zhengzhi Wu; Ronghua Zhang
Journal:  RSC Adv       Date:  2019-10-08       Impact factor: 3.361

3.  Improving Antibody-Tubulysin Conjugates through Linker Chemistry and Site-Specific Conjugation.

Authors:  Joseph Z Hamilton; Thomas A Pires; Jamie A Mitchell; Julia H Cochran; Kim K Emmerton; Margo Zaval; Ivan J Stone; Martha E Anderson; Steven Jin; Andrew B Waight; Robert P Lyon; Peter D Senter; Scott C Jeffrey; Patrick J Burke
Journal:  ChemMedChem       Date:  2021-02-12       Impact factor: 3.540

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.